DICE Therapeutics Inc.

NASDAQ: DICE · Real-Time Price · USD
47.55
0.03 (0.06%)
At close: Aug 08, 2023, 10:00 PM

DICE Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
461.39M 115.83M
Short-Term Investments
112.83M 203.5M
Long-Term Investments
n/a n/a
Other Long-Term Assets
198K 198K
Receivables
n/a 2M
Inventory
n/a n/a
Other Current Assets
3.54M 2.59M
Total Current Assets
577.76M 323.91M
Property-Plant & Equipment
16.02M 1.65M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
16.22M 1.84M
Total Assets
593.98M 325.75M
Account Payables
3.08M 1.71M
Deferred Revenue
n/a n/a
Short-Term Debt
1.42M 480K
Other Current Liabilities
10.65M 8.69M
Total Current Liabilities
15.15M 10.88M
Long-Term Debt
11.84M 1.92M
Other Long-Term Liabilities
n/a 8K
Total Long-Term Liabilities
11.84M 1.92M
Total Liabilities
26.99M 12.8M
Total Debt
13.27M 2.4M
Common Stock
5K 4K
Retained Earnings
-187.59M -103.71M
Comprehensive Income
-597K -58K
Shareholders Equity
-187.59M -103.71M
Total Investments
112.83M 203.5M